Product NDC: | 45802-106 |
Proprietary Name: | Loratadine D |
Non Proprietary Name: | Loratadine, Pseudoephedrine |
Active Ingredient(s): | 5; 120 mg/1; mg/1 & nbsp; Loratadine, Pseudoephedrine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-106 |
Labeler Name: | Perrigo New York Inc |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA076050 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120119 |
Package NDC: | 45802-106-60 |
Package Description: | 2 BLISTER PACK in 1 CARTON (45802-106-60) > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
NDC Code | 45802-106-60 |
Proprietary Name | Loratadine D |
Package Description | 2 BLISTER PACK in 1 CARTON (45802-106-60) > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Product NDC | 45802-106 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Loratadine, Pseudoephedrine |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120119 |
Marketing Category Name | ANDA |
Labeler Name | Perrigo New York Inc |
Substance Name | LORATADINE; PSEUDOEPHEDRINE SULFATE |
Strength Number | 5; 120 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |